Theradaptive’s Chief Scientific Officer Frank Vizesi provides an overview of the company’s unique protei...
The Musculoskeletal New Ventures Conference meeting offers a glimpse into emerging and promising technol...
Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide En...
NASS Executive Director and CEO Eric Muehlbauer discusses NASS’s new Innovation NetWORK Summit in an int...
Spinal Simplicity’s Chief Strategy Officer Neil P. Dougherty shares how the company is advancing minimal...
Allumin8 CEO Alyssa Huffman discusses the company's novel therapeutic hardware during an interview with ...
SmartTRAK discusses key products and compelling clinical evidence that may impact the Bone Replacement M...
SmartTRAK will be attending AAOS 2025 this week. Join us at AAOS to explore our solution and discuss our...
New spine technologies "pushed the envelope" at MNVC The Musculoskeletal New Ventures Conference (MNVC) ...
New products and clinical data continue to grow the spinal hardware and bone replacement markets. The No...